scispace - formally typeset
M

Masako Seki

Researcher at Kagawa University

Publications -  23
Citations -  2439

Masako Seki is an academic researcher from Kagawa University. The author has contributed to research in topics: Galectin & Eosinophil. The author has an hindex of 16, co-authored 23 publications receiving 2276 citations. Previous affiliations of Masako Seki include Brigham and Women's Hospital & La Jolla Institute for Allergy and Immunology.

Papers
More filters
Journal ArticleDOI

Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes

TL;DR: The finding that the ecalectin transcript is present in abundance in various lymphatic tissues and that its expression increases substantially in antigen-activated peripheral blood mononuclear cells suggests that ecalECTin is an important T-cell-derived regulator of eosinophil recruitment in tissues during inflammatory reactions.
Journal ArticleDOI

Galectin-9 Induces Apoptosis Through the Calcium-Calpain-Caspase-1 Pathway

TL;DR: Gal-9 induces apoptosis via the Ca2+-calpain-caspase-1 pathway, and that Gal-9 plays a role in immunomodulation of T cell-mediated immune responses is suggested.
Journal ArticleDOI

Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance.

TL;DR: High galectin‐9 expression was inversely correlated with the progression of this disease, suggesting that high galect in‐depth expression in primary melanoma lesions links to a better prognosis.
Journal ArticleDOI

Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer.

TL;DR: Multivariate analysis revealed that galectin-9 status influenced distant metastasis independently of and to a greater extent than lymph node metastasis in patients with breast cancer.